Transthyretin Amyloidosis Treatment Market Report 2026
Download Free Sample Buy Now
Transthyretin Amyloidosis Treatment Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Transthyretin Amyloidosis Treatment Market Report 2026

Global Outlook – By Type (Transthyretin Amyloidosis With Polyneuropathy (ATTR-PN), Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)), By Drug (Tafamidis, Patisiran, Inotersen, Other Drugs), By Therapy (Targeted Therapy, Supportive Therapy, Pipeline Therapy), By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Retail Pharmacies, Online Pharmacies) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Transthyretin Amyloidosis Treatment Market Overview

• Transthyretin Amyloidosis Treatment market size has reached to $4.96 billion in 2025

• Expected to grow to $7.42 billion in 2030 at a compound annual growth rate (CAGR) of 8.5%

• Growth Driver: The Rise In Research And Development Investments Driving The Growth Of The Market Due To Increased Innovation And Therapy Advancement

• Market Trend: Innovative Orphan Drug Combinations Transforming The Landscape Of Transthyretin Amyloidosis Treatment

• North America was the largest region in 2025.

What Is Covered Under Transthyretin Amyloidosis Treatment Market?

Transthyretin amyloidosis is a slowly progressive condition characterized by the buildup of abnormal protein deposits in the body's organs and tissues. Transthyretin amyloidosis treatment refers to the medical interventions and therapeutic strategies designed to manage and mitigate the effects of transthyretin amyloidosis (ATTR).

The main types of transthyretin amyloidosis treatment include transthyretin amyloidosis with polyneuropathy (ATTR-PN) and transthyretin amyloidosis with cardiomyopathy (ATTR-CM). Transthyretin amyloidosis with polyneuropathy (ATTR-PN) refers to a type of amyloidosis characterized by the deposition of abnormal transthyretin protein in nerves, leading to peripheral neuropathy and other neurological symptoms. These disease types are treated with drugs such as tafamidis, patisiran, inotersen, and others, along with targeted therapy, supportive therapy, and pipeline therapies, which are distributed through channels including hospital pharmacies, specialty pharmacies, retail pharmacies, and online pharmacies.

Transthyretin Amyloidosis Treatment Market Global Report 2026 Market Report bar graph

What Is The Transthyretin Amyloidosis Treatment Market Size and Share 2026?

The transthyretin amyloidosis treatment market size has grown strongly in recent years. It will grow from $4.96 billion in 2025 to $5.36 billion in 2026 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to increased recognition of hereditary amyloidosis, expansion of genetic testing availability, introduction of disease-modifying drugs, improved specialist referral networks, growing rare disease registries.

What Is The Transthyretin Amyloidosis Treatment Market Growth Forecast?

The transthyretin amyloidosis treatment market size is expected to see strong growth in the next few years. It will grow to $7.42 billion in 2030 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to advancement of next-generation attr therapies, increasing investments in pipeline and combination treatments, broader access to specialty pharmacies, rising demand for personalized therapy selection, continued expansion of clinical trial activity. Major trends in the forecast period include increasing development of targeted attr therapies, rising adoption of gene silencing drugs, growing focus on multisystem disease management, expansion of pipeline therapies for attr variants, improved patient stratification and monitoring.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Transthyretin Amyloidosis Treatment Market Segmentation

1) By Type: Transthyretin Amyloidosis With Polyneuropathy (ATTR-PN), Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)

2) By Drug: Tafamidis, Patisiran, Inotersen, Other Drugs

3) By Therapy: Targeted Therapy, Supportive Therapy, Pipeline Therapy

4) By Distribution Channel: Hospital Pharmacies, Specialty Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Transthyretin Amyloidosis With Polyneuropathy (ATTR-PN): Early-Stage ATTR-PN, Advanced-Stage ATTR-PN

2) By Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM): Mild ATTR-CM, Moderate ATTR-CM, Severe ATTR-CM

What Is The Driver Of The Transthyretin Amyloidosis Treatment Market?

The rising investments in research and development (R&D) are expected to propel the growth of the transthyretin amyloidosis treatment market going forward. research and development investments refer to financial resources dedicated to discovering new therapies, improving existing treatments, and advancing scientific understanding across disease areas. R&D funding is increasing as governments and private sectors expand their focus on rare diseases, precision medicine, and next-generation therapeutic platforms. Rising investments in research and development accelerate the discovery and advancement of innovative therapies, improving treatment options and outcomes for transthyretin amyloidosis patients. For instance, in November 2023, according to the report published by the European Federation of Pharmaceutical Industries and Associations, a Belgium-based trade association, pharmaceutical industry research and development expenditure rose to 50,000 million in 2023, up from 47,010 million in 2022. Therefore, rising research and development investments are driving the growth of the transthyretin amyloidosis treatment industry.

Key Players In The Global Transthyretin Amyloidosis Treatment Market

Major companies operating in the transthyretin amyloidosis treatment market are Pfizer Inc, Alnylam Pharmaceuticals Inc, Ionis Pharmaceuticals, Prothena Corporation plc, Eidos Therapeutics Inc, BridgeBio Pharma Inc, Neurimmune AG, AstraZeneca plc, Intellia Therapeutics Inc, Novo Nordisk A/S, YolTech Therapeutics Co Ltd, Life Molecular Imaging GmbH, Attralus Inc, Regeneron Pharmaceuticals, Silence Therapeutics, Proclara Biosciences, Corino Therapeutics, SOM Biotech, Oncopeptides AB, Takeda Pharmaceutical Company Limited, Horizon Therapeutics, Roche Holding AG, SOM Innovation Biotech SA

Global Transthyretin Amyloidosis Treatment Market Trends and Insights

Major companies in the transthyretin amyloidosis treatment market focus on developing innovative and specialized treatments, such as orphan drugs, to enhance patient outcomes and expand treatment options. Eplontersen is an orphan drug specifically designed to treat transthyretin amyloidosis condition, often receiving regulatory benefits to support its development. For instance, in March 2023, Ionis Pharmaceuticals, Inc., a Canada-based biotechnology research company, received The Food and Drug Administration (FDA) approval of a new drug application for Eplontersen, an experimental orphan drug intended for the treatment of familial transthyretin-mediated amyloid, leading to progressive polyneuropathy. Eplontersen is a pharmaceutical agent developed to mitigate the synthesis of transthyretin (TTR) protein to address both the hereditary and non-hereditary variations of ATTR amyloidosis (amyloid transthyretin amyloidosis).

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Transthyretin Amyloidosis Treatment Market?

In April 2024, BridgeBio Pharma, a US-based biotech company, collaborated with Bayer. This partnership aimed at treating transthyretin amyloid cardiomyopathy (ATTR-CM) in Europe. Under the deal, Bayer will exclusively commercialize the drug, with BridgeBio receiving up to $310 million in payments and royalties. This collaboration enhances the potential availability of acoramidis for patients suffering from this serious condition. Bayer is a Germany-based Life Science company.

Regional Outlook

North America was the largest region in the transthyretin amyloidosis treatment market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Transthyretin Amyloidosis Treatment Market?

The transthyretin amyloidosis treatment market consists of revenues earned by entities by providing biopsy, echocardiography, genetic testing, and imaging studies. The market value includes the value of related goods sold by the service provider or included within the service offering. The transthyretin amyloidosis treatment market also includes sales of tolcapone, and diflunisal. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Transthyretin Amyloidosis Treatment Market Report 2026?

The transthyretin amyloidosis treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the transthyretin amyloidosis treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Transthyretin Amyloidosis Treatment Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $5.36 billion
Revenue Forecast In 2035 $7.42 billion
Growth Rate CAGR of 8.1% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Type, Drug, Therapy, Distribution Channel
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Pfizer Inc, Alnylam Pharmaceuticals Inc, Ionis Pharmaceuticals, Prothena Corporation plc, Eidos Therapeutics Inc, BridgeBio Pharma Inc, Neurimmune AG, AstraZeneca plc, Intellia Therapeutics Inc, Novo Nordisk A/S, YolTech Therapeutics Co Ltd, Life Molecular Imaging GmbH, Attralus Inc, Regeneron Pharmaceuticals, Silence Therapeutics, Proclara Biosciences, Corino Therapeutics, SOM Biotech, Oncopeptides AB, Takeda Pharmaceutical Company Limited, Horizon Therapeutics, Roche Holding AG, SOM Innovation Biotech SA
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Transthyretin Amyloidosis Treatment Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Transthyretin Amyloidosis Treatment Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Transthyretin Amyloidosis Treatment Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Transthyretin Amyloidosis Treatment Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Increasing Development Of Targeted Attr Therapies

4.2.2 Rising Adoption Of Gene Silencing Drugs

4.2.3 Growing Focus On Multisystem Disease Management

4.2.4 Expansion Of Pipeline Therapies For Attr Variants

4.2.5 Improved Patient Stratification And Monitoring

5. Transthyretin Amyloidosis Treatment Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Specialty Clinics

5.3 Neurology Centers

5.4 Cardiology Centers

5.5 Specialty Pharmacies

6. Transthyretin Amyloidosis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Transthyretin Amyloidosis Treatment Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Transthyretin Amyloidosis Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Transthyretin Amyloidosis Treatment Market Size, Comparisons And Growth Rate Analysis

7.3. Global Transthyretin Amyloidosis Treatment Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Transthyretin Amyloidosis Treatment Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Transthyretin Amyloidosis Treatment Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Transthyretin Amyloidosis Treatment Market Segmentation

9.1. Global Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Transthyretin Amyloidosis With Polyneuropathy (ATTR-PN), Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)

9.2. Global Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Tafamidis, Patisiran, Inotersen, Other Drugs

9.3. Global Transthyretin Amyloidosis Treatment Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Targeted Therapy, Supportive Therapy, Pipeline Therapy

9.4. Global Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacies, Specialty Pharmacies, Retail Pharmacies, Online Pharmacies

9.5. Global Transthyretin Amyloidosis Treatment Market, Sub-Segmentation Of Transthyretin Amyloidosis With Polyneuropathy (ATTR-PN), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Early-Stage ATTR-PN, Advanced-Stage ATTR-PN

9.6. Global Transthyretin Amyloidosis Treatment Market, Sub-Segmentation Of Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Mild ATTR-CM, Moderate ATTR-CM, Severe ATTR-CM

10. Transthyretin Amyloidosis Treatment Market Regional And Country Analysis

10.1. Global Transthyretin Amyloidosis Treatment Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Transthyretin Amyloidosis Treatment Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Transthyretin Amyloidosis Treatment Market

11.1. Asia-Pacific Transthyretin Amyloidosis Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Segmentation By Drug, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Transthyretin Amyloidosis Treatment Market

12.1. China Transthyretin Amyloidosis Treatment Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Segmentation By Drug, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Transthyretin Amyloidosis Treatment Market

13.1. India Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Segmentation By Drug, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Transthyretin Amyloidosis Treatment Market

14.1. Japan Transthyretin Amyloidosis Treatment Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Segmentation By Drug, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Transthyretin Amyloidosis Treatment Market

15.1. Australia Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Segmentation By Drug, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Transthyretin Amyloidosis Treatment Market

16.1. Indonesia Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Segmentation By Drug, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Transthyretin Amyloidosis Treatment Market

17.1. South Korea Transthyretin Amyloidosis Treatment Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Segmentation By Drug, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Transthyretin Amyloidosis Treatment Market

18.1. Taiwan Transthyretin Amyloidosis Treatment Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Segmentation By Drug, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Transthyretin Amyloidosis Treatment Market

19.1. South East Asia Transthyretin Amyloidosis Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Segmentation By Drug, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Transthyretin Amyloidosis Treatment Market

20.1. Western Europe Transthyretin Amyloidosis Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Segmentation By Drug, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Transthyretin Amyloidosis Treatment Market

21.1. UK Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Segmentation By Drug, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Transthyretin Amyloidosis Treatment Market

22.1. Germany Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Segmentation By Drug, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Transthyretin Amyloidosis Treatment Market

23.1. France Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Segmentation By Drug, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Transthyretin Amyloidosis Treatment Market

24.1. Italy Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Segmentation By Drug, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Transthyretin Amyloidosis Treatment Market

25.1. Spain Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Segmentation By Drug, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Transthyretin Amyloidosis Treatment Market

26.1. Eastern Europe Transthyretin Amyloidosis Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Segmentation By Drug, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Transthyretin Amyloidosis Treatment Market

27.1. Russia Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Segmentation By Drug, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Transthyretin Amyloidosis Treatment Market

28.1. North America Transthyretin Amyloidosis Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Segmentation By Drug, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Transthyretin Amyloidosis Treatment Market

29.1. USA Transthyretin Amyloidosis Treatment Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Segmentation By Drug, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Transthyretin Amyloidosis Treatment Market

30.1. Canada Transthyretin Amyloidosis Treatment Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Segmentation By Drug, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Transthyretin Amyloidosis Treatment Market

31.1. South America Transthyretin Amyloidosis Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Segmentation By Drug, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Transthyretin Amyloidosis Treatment Market

32.1. Brazil Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Segmentation By Drug, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Transthyretin Amyloidosis Treatment Market

33.1. Middle East Transthyretin Amyloidosis Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Segmentation By Drug, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Transthyretin Amyloidosis Treatment Market

34.1. Africa Transthyretin Amyloidosis Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Segmentation By Drug, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Transthyretin Amyloidosis Treatment Market Regulatory and Investment Landscape

36. Transthyretin Amyloidosis Treatment Market Competitive Landscape And Company Profiles

36.1. Transthyretin Amyloidosis Treatment Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Transthyretin Amyloidosis Treatment Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Transthyretin Amyloidosis Treatment Market Company Profiles

36.3.1. Pfizer Inc Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Alnylam Pharmaceuticals Inc Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Ionis Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Prothena Corporation plc Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Eidos Therapeutics Inc Overview, Products and Services, Strategy and Financial Analysis

37. Transthyretin Amyloidosis Treatment Market Other Major And Innovative Companies

BridgeBio Pharma Inc, Neurimmune AG, AstraZeneca plc, Intellia Therapeutics Inc, Novo Nordisk A/S, YolTech Therapeutics Co Ltd, Life Molecular Imaging GmbH, Attralus Inc, Regeneron Pharmaceuticals, Silence Therapeutics, Proclara Biosciences, Corino Therapeutics, SOM Biotech, Oncopeptides AB, Takeda Pharmaceutical Company Limited

38. Global Transthyretin Amyloidosis Treatment Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Transthyretin Amyloidosis Treatment Market

40. Transthyretin Amyloidosis Treatment Market High Potential Countries, Segments and Strategies

40.1 Transthyretin Amyloidosis Treatment Market In 2030 - Countries Offering Most New Opportunities

40.2 Transthyretin Amyloidosis Treatment Market In 2030 - Segments Offering Most New Opportunities

40.3 Transthyretin Amyloidosis Treatment Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Transthyretin Amyloidosis Treatment Market, Overview Of Key Products - Product Examples
  • Table 2: Global Transthyretin Amyloidosis Treatment Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Transthyretin Amyloidosis Treatment Market, Supply Chain Analysis
  • Table 4: Global Transthyretin Amyloidosis Treatment Market, Major Raw Material Providers
  • Table 5: Global Transthyretin Amyloidosis Treatment Market, Major Resource Providers
  • Table 6: Global Transthyretin Amyloidosis Treatment Market, Major Manufacturers (Suppliers)
  • Table 7: Global Transthyretin Amyloidosis Treatment Market, Major Distributors And Channel Partners
  • Table 8: Global Transthyretin Amyloidosis Treatment Market, Key Technologies & Future Trends
  • Table 9: Global Transthyretin Amyloidosis Treatment Market, Major Trends
  • Table 10: Global Transthyretin Amyloidosis Treatment Market, Major End Users
  • Table 11: Global Transthyretin Amyloidosis Treatment Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Transthyretin Amyloidosis Treatment Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Transthyretin Amyloidosis Treatment Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Transthyretin Amyloidosis Treatment Market - TAM, US$ Billion, 2025
  • Table 15: Global Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Transthyretin Amyloidosis Treatment Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Transthyretin Amyloidosis Treatment Market, Sub-Segmentation Of Transthyretin Amyloidosis With Polyneuropathy (ATTR-PN), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Transthyretin Amyloidosis Treatment Market, Sub-Segmentation Of Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Transthyretin Amyloidosis Treatment Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Transthyretin Amyloidosis Treatment Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Transthyretin Amyloidosis Treatment Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Transthyretin Amyloidosis Treatment Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Transthyretin Amyloidosis Treatment Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Transthyretin Amyloidosis Treatment Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Transthyretin Amyloidosis Treatment Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Indonesia, Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Transthyretin Amyloidosis Treatment Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: South Korea, Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Transthyretin Amyloidosis Treatment Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Taiwan, Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Transthyretin Amyloidosis Treatment Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South East Asia, Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Transthyretin Amyloidosis Treatment Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Western Europe, Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Transthyretin Amyloidosis Treatment Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: UK, Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Transthyretin Amyloidosis Treatment Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Germany, Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Transthyretin Amyloidosis Treatment Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: France, Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Transthyretin Amyloidosis Treatment Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Italy, Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Transthyretin Amyloidosis Treatment Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Spain, Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Transthyretin Amyloidosis Treatment Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Eastern Europe, Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Transthyretin Amyloidosis Treatment Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Russia, Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Transthyretin Amyloidosis Treatment Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: North America, Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Transthyretin Amyloidosis Treatment Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: USA, Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Transthyretin Amyloidosis Treatment Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: Canada, Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Transthyretin Amyloidosis Treatment Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: South America, Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Transthyretin Amyloidosis Treatment Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Brazil, Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Transthyretin Amyloidosis Treatment Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Middle East, Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Transthyretin Amyloidosis Treatment Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Africa, Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Transthyretin Amyloidosis Treatment Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Global Transthyretin Amyloidosis Treatment Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 96: Global Transthyretin Amyloidosis Treatment Market - Company Scoring Matrix
  • Table 97: Pfizer Inc Financial Performance
  • Table 98: Alnylam Pharmaceuticals Inc Financial Performance
  • Table 99: Ionis Pharmaceuticals Financial Performance
  • Table 100: Prothena Corporation plc Financial Performance
  • Table 101: Eidos Therapeutics Inc Financial Performance
  • Table 102: Global Transthyretin Amyloidosis Treatment Market, Competitive Benchmarking (In USD Billions)
  • Table 103: Global Transthyretin Amyloidosis Treatment Market, Competitive Dashboard
  • Table 104: Global Transthyretin Amyloidosis Treatment Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 105: Global, Transthyretin Amyloidosis Treatment Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Table 106: Global, Transthyretin Amyloidosis Treatment Market Size Gain ($ Billion), Segmentation By Drug, 2025 – 2030
  • Table 107: Global, Transthyretin Amyloidosis Treatment Market Size Gain ($ Billion), Segmentation By Therapy, 2025 – 2030

List Of Figures

    Figure 1: Global Transthyretin Amyloidosis Treatment Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Transthyretin Amyloidosis Treatment Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Transthyretin Amyloidosis Treatment Market, Supply Chain Analysis
  • Figure 4: Global Transthyretin Amyloidosis Treatment Market, Major Raw Material Providers
  • Figure 5: Global Transthyretin Amyloidosis Treatment Market, Major Resource Providers
  • Figure 6: Global Transthyretin Amyloidosis Treatment Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Transthyretin Amyloidosis Treatment Market, Major Distributors And Channel Partners
  • Figure 8: Global Transthyretin Amyloidosis Treatment Market, Key Technologies & Future Trends
  • Figure 9: Global Transthyretin Amyloidosis Treatment Market, Major Trends
  • Figure 10: Global Transthyretin Amyloidosis Treatment Market, Major End Users
  • Figure 11: Global Transthyretin Amyloidosis Treatment Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Transthyretin Amyloidosis Treatment Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Transthyretin Amyloidosis Treatment Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Transthyretin Amyloidosis Treatment Market - TAM, US$ Billion, 2025
  • Figure 15: Global Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Transthyretin Amyloidosis Treatment Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Transthyretin Amyloidosis Treatment Market, Sub-Segmentation Of Transthyretin Amyloidosis With Polyneuropathy (ATTR-PN), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Transthyretin Amyloidosis Treatment Market, Sub-Segmentation Of Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Transthyretin Amyloidosis Treatment Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Transthyretin Amyloidosis Treatment Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Transthyretin Amyloidosis Treatment Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Transthyretin Amyloidosis Treatment Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Transthyretin Amyloidosis Treatment Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Transthyretin Amyloidosis Treatment Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Transthyretin Amyloidosis Treatment Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Indonesia, Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Transthyretin Amyloidosis Treatment Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: South Korea, Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Transthyretin Amyloidosis Treatment Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Taiwan, Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Transthyretin Amyloidosis Treatment Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South East Asia, Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Transthyretin Amyloidosis Treatment Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Western Europe, Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Transthyretin Amyloidosis Treatment Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: UK, Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Transthyretin Amyloidosis Treatment Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Germany, Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Transthyretin Amyloidosis Treatment Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: France, Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Transthyretin Amyloidosis Treatment Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Italy, Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Transthyretin Amyloidosis Treatment Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Spain, Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Transthyretin Amyloidosis Treatment Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Eastern Europe, Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Transthyretin Amyloidosis Treatment Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Russia, Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Transthyretin Amyloidosis Treatment Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: North America, Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Transthyretin Amyloidosis Treatment Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: USA, Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Transthyretin Amyloidosis Treatment Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: Canada, Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Transthyretin Amyloidosis Treatment Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: South America, Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Transthyretin Amyloidosis Treatment Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Brazil, Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Transthyretin Amyloidosis Treatment Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Middle East, Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Transthyretin Amyloidosis Treatment Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Africa, Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Transthyretin Amyloidosis Treatment Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Global Transthyretin Amyloidosis Treatment Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 96: Global Transthyretin Amyloidosis Treatment Market - Company Scoring Matrix
  • Figure 97: Pfizer Inc Financial Performance
  • Figure 98: Alnylam Pharmaceuticals Inc Financial Performance
  • Figure 99: Ionis Pharmaceuticals Financial Performance
  • Figure 100: Prothena Corporation plc Financial Performance
  • Figure 101: Eidos Therapeutics Inc Financial Performance
  • Figure 102: Global Transthyretin Amyloidosis Treatment Market, Competitive Benchmarking (In USD Billions)
  • Figure 103: Global Transthyretin Amyloidosis Treatment Market, Competitive Dashboard
  • Figure 104: Global Transthyretin Amyloidosis Treatment Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 105: Global, Transthyretin Amyloidosis Treatment Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Figure 106: Global, Transthyretin Amyloidosis Treatment Market Size Gain ($ Billion), Segmentation By Drug, 2025 – 2030
  • Figure 107: Global, Transthyretin Amyloidosis Treatment Market Size Gain ($ Billion), Segmentation By Therapy, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

Read More About Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Read More About Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Read More About A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Read More About A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Transthyretin Amyloidosis Treatment Market Report 2026 - Global Outlook – By Type (Transthyretin Amyloidosis With Polyneuropathy (ATTR-PN), Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)), By Drug (Tafamidis, Pa...

Atrophic Glossitis Treatment Market Report 2026 - Global Outlook – By Treatment Type (Medications, Topical Treatments, Nutritional Supplements, Oral Care Products), By Symptoms (Inflammation, Discoloration, Itching, Burn...

Keloids Treatment Market Report 2026 - Global Outlook – By Product Type (Topical Products, Injectable Products, Medical Devices), By Treatment (Radiation Therapy, Cryo Therapy, Surgical Treatment, Laser Treatment, Steroi...

Pigmentation Disorders Treatment Market Report 2026 - Global Outlook – By Treatment Type (Topical Treatment, Dermabrasion, Chemical Peels, Laser Treatment, Phototherapy, Other Treatment Types), By Drugs (Calcineurin Inhi...

Neurofibromatosis Treatment Market Report 2026 - Global Outlook – By Type (Neurofibromatosis 1 (NF1), Neurofibromatosis 2 (NF2), Schwannomatosis), By Treatment (Medications, Surgery, Radiation Therapy, Other Treatments),...

Alzheimer's Drugs Market Report 2026 - Global Outlook – By Drugs (Donepezil, Rivastigmine, Galantamine, Memantine ), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy ), By Application (Early T...

Anti-Thyroid Drugs Market Report 2026 - Global Outlook – By Drug Type (Thionamides (Inhibition Of Hormone Synthesis), Iodides (Inhibition Of Hormone Release)), By Route of Administration (Oral, Intravenous, Other Route O...

Enzyme Replacement Therapy Market Report 2026 - Global Outlook – By Enzyme Type (Agalsidase Alfa, Agalsidase Beta, Galsulfase, Other Enzyme Types), By Route Of Administration (Oral, Parenteral ), By Application (Gaucher ...

Frequently Asked Questions

The Transthyretin Amyloidosis Treatment market was valued at $4.96 billion in 2025, increased to $5.36 billion in 2026, and is projected to reach $7.42 billion by 2030.

The global Transthyretin Amyloidosis Treatment market is expected to grow at a CAGR of 8.5% from 2026 to 2035 to reach $7.42 billion by 2035.

Some Key Players in the Transthyretin Amyloidosis Treatment market Include, Pfizer Inc, Alnylam Pharmaceuticals Inc, Ionis Pharmaceuticals, Prothena Corporation plc, Eidos Therapeutics Inc, BridgeBio Pharma Inc, Neurimmune AG, AstraZeneca plc, Intellia Therapeutics Inc, Novo Nordisk A/S, YolTech Therapeutics Co Ltd, Life Molecular Imaging GmbH, Attralus Inc, Regeneron Pharmaceuticals, Silence Therapeutics, Proclara Biosciences, Corino Therapeutics, SOM Biotech, Oncopeptides AB, Takeda Pharmaceutical Company Limited, Horizon Therapeutics, Roche Holding AG, SOM Innovation Biotech SA .

Major trend in this market includes: Innovative Orphan Drug Combinations Transforming The Landscape Of Transthyretin Amyloidosis Treatment. For further insights on this market. request a sample here

North America was the largest region in the transthyretin amyloidosis treatment market in 2025. The regions covered in the transthyretin amyloidosis treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us